about
Nutrition in the acute phase of critical illnessEarly enteral nutrition in critically ill patients: ESICM clinical practice guidelines.Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophagesThe nutritional energy to clinical outcome relation revisited.Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: a randomized, controlled clinical study.Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis.Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial.Enteral nutrition: better navigation, yet unknown destination?Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial.Bench-to-bedside review: metabolism and nutrition.Does artificial nutrition improve outcome of critical illness?Muscle weakness and nutrition therapy in ICU.Metabolic and nutritional support of critically ill patients: consensus and controversies.Nutritional support in critical illness and recovery.The intensive care medicine research agenda in nutrition and metabolism.AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin.Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trial.Early versus Late Parenteral Nutrition in Critically Ill Children.Editorial on the original article entitled "Permissive underfeeding of standard enteral feeding in critically ill adults" published in the New England Journal of Medicine on June 18, 2015.Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU.Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge.Supplemental parenteral nutrition in critically ill patients.Outcome following severe burn injuries in Belgium.Inter-observer agreement of Medical Research Council-sum score and handgrip strength in the ICU.Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU.Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study.Monitoring enteral nutrition efficacy in ICU patients: is there a place for the Brix value-derived fraction of enteral formula in gastric residual volume?Impact of early parenteral nutrition on catabolism.37th International Symposium on Intensive Care and Emergency Medicine (part 1 of 3): Brussels, Belgium. 21–24 March 2017.Withholding parenteral nutrition for 1 week reduces ICU-acquired weakness.Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness.Withholding parenteral nutrition during the first week of critical illness increases plasma bilirubin but lowers the incidence of cholestasis and gallbladder sludge.Near-Infrared Cerebral Oximetry to Predict Outcome After Pediatric Cardiac Surgery: A Prospective Observational Study.Optimal guidance for early nutrition therapy in critical illness?Nutrition in the ICU: sometimes route does matter.Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness.Comment on "Protein Requirements in the Critically Ill: A Randomized Controlled Trial Using Parenteral Nutrition".Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial.Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma.Nutrition in the Acute Phase of Critical Illness
P50
Q26829307-795DAF49-C1BC-46A2-804F-59F5075CE0ACQ30238512-C03711AE-F9D3-4D42-BFE5-A122AE20ACA9Q33751235-C4394DB9-FE85-4286-B9DC-B110E1D2016CQ33762737-43BB82B5-BA40-470C-A181-1E558A9D27F0Q34324235-70151439-9590-42A1-878B-9BDE9009AAA8Q34419891-E1F3D2BA-8A31-42FA-A9AF-21C7F4063481Q34552719-DBA33571-B045-4792-B3B1-122A406205D7Q36073021-5BB41A16-4124-42FE-84A0-8F79C716055FQ36633647-F46722C6-E883-45DC-A991-43E1E87F22F7Q36955190-F8ED25AF-A8D5-491F-8A5B-0F3488D4E732Q38078581-93D7F4C7-569A-4454-A4B4-70840A6D6428Q38324991-6B562079-85A4-4E50-BB27-86EDBB8DDD71Q38426589-B2BB9921-94EC-4363-98AE-FED0E406474CQ38527073-A6009344-5C6A-4B10-8AFF-5D29A07F8B98Q38735448-8A392044-9CA0-4BEF-87EF-5EC1A77CFEF4Q38994344-5EF8105F-650B-4B18-93F6-F3BDD7E3EC49Q40206885-70CABCB3-E3D7-47C5-8F9A-321AD372330AQ40756098-D72D9A9D-B557-4CE5-8071-2AD4EAAD3A86Q41093335-EC087897-DF46-43BC-B0B3-CE2984B5A5DAQ41489882-8E96254E-7B23-4230-A150-EC57A63A33A3Q43478259-222FFCC3-EFB3-44EC-8F3C-B66B440DD0B5Q44811272-AD3B7806-A3BD-49EF-BC77-AA07140836D6Q45792928-35EBDA86-9DDF-4A6C-B138-4D12B774C1B5Q45863938-D24A638A-C3F0-4AF9-8886-ADCD854171D9Q46057592-89C0321D-D259-4236-925B-8F94103151FBQ46142548-51E9839C-97EE-4FE3-AF74-73E3AC0980D4Q46288044-601329C8-1811-4EE2-8F54-51FEA5D7CA2AQ46713733-172124AB-CB14-42E2-AAE9-27BE01836E4EQ46974244-4316C0AF-918C-4E66-96A5-BD534A4BCFB3Q47095770-A91123ED-322A-49CE-8893-DB2B9FF189ABQ47131584-C1882AE9-5700-466A-B2CA-B16110162AEAQ47146201-A62E9BF6-0006-4595-99D1-F6D4BD022226Q49711656-39674307-3631-443F-ADCA-EE48C46835CAQ49943008-BB7A3482-2AF0-443C-A071-613E7B4E6E61Q50058714-12AF3BD1-611E-4D6B-ABF5-8A415186FBC0Q50792385-238E1F75-EBEA-42D2-BA72-A0CFB7317A45Q51627911-CEDE2720-583F-4E76-A0C0-5BB14FA5E84CQ53070565-C7B15351-BE1A-4855-B672-C595521FBF1CQ55246940-32CE5FA5-985E-4FC8-9A47-7E1A1170115EQ57245202-E1B316D0-F264-45AF-BEA9-83C8B4CCD264
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7087-0795
@en
name
Michael P Casaer
@ast
Michael P Casaer
@en
Michael P Casaer
@es
Michael P Casaer
@nl
type
label
Michael P Casaer
@ast
Michael P Casaer
@en
Michael P Casaer
@es
Michael P Casaer
@nl
prefLabel
Michael P Casaer
@ast
Michael P Casaer
@en
Michael P Casaer
@es
Michael P Casaer
@nl
P106
P31
P496
0000-0002-7087-0795